Lexicon Pharmaceuticals | LXRX - Mitarbeiter Gesamtzahl

Aktienkurs
2.34
Täglich Wechseln
0.34 16.75%
Monatlich
32.67%
Jährlich
233.10%
Q2 Prognose
1.96




Mitarbeiter Veränderung Datum
Abbott 114K 1000 2023-12
Acadia Pharmaceuticals 653 56 2024-12
Agios Pharmaceuticals 486 103 2024-12
Akebia Therapeutics 167 37 2023-12
Alnylam Pharmaceuticals 2.23K 130 2024-12
AstraZeneca USD 89.9K 6.4K 2023-12
BioMarin Pharmaceutical 3.04K 361 2024-12
Coherus Biosciences 306 53 2023-12
Eli Lilly 47K 4K 2024-12
Esperion Therapeutics 240 41 2023-12
Halozyme Therapeutics 350 23 2024-12
Illumina 8.97K 1.62K 2024-12
Insmed 1.27K 359 2024-12
Ironwood Pharmaceuticals 267 48 2023-12
J&J 138.1K 6.2K 2024-12
Lexicon Pharmaceuticals 285 150 2023-12
MacroGenics 339 18 2023-12
MannKind 407 7 2024-12
Merck 75K 3K 2024-12
Moderna 5.8K 200 2024-12
Novartis USD 101.7K 2.62K 2022-12
PTC Therapeutics 939 49 2024-12
Puma Biotechnology 185 7 2023-12
Sarepta Therapeutics 1.37K 58 2024-12
Thermo Fisher Scientific 125K 3K 2024-12
Ultragenyx Pharmaceutical 1.29K 18 2024-12
United Therapeutics 1.3K 137 2024-12
Vanda Pharmaceuticals 203 87 2023-12